Gene · 4191
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Antiplatelet therapy on metastatic paraganglioma-associated cutaneous vascular disease and literature review. | Front Med (Lausanne) | 2022 | 36465918 | PubTator, text mining | PubMed |
| Nuclear localization of mitochondrial TCA cycle enzymes modulates pluripotency via histone acetylation. | Nat Commun | 2022 | 36460681 | PubTator, text mining | PubMed |
| Competitive Transmission of Carbapenem-Resistant Klebsiella pneumoniae in a Newly Opened Intensive Care Unit. | mSystems | 2022 | 36445111 | PubTator, text mining | PubMed |
| Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. | J Hematol Oncol | 2022 | 36434634 | PubTator, text mining | PubMed |
Cytotoxicity, Mitochondrial Functionality, and Redox Status of Human Conjunctival Cells after Short and Chronic Exposure to Preservative-Free Bimatoprost 0.03% and 0.01%: An In Vitro Comparative Study. | Int J Mol Sci | 2022 | 36430590 | PubTator, text mining | PubMed |
| Amino Acids in Cancer and Cachexia: An Integrated View. | Cancers (Basel) | 2022 | 36428783 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| Colonization with Carbapenem-Resistant Enterobacteriaceae Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients. | Antibiotics (Basel) | 2022 | 36421311 | PubTator, text mining | PubMed |
| Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signature. | Mol Genet Metab Rep | 2022 | 36420423 | PubTator, text mining | PubMed |
| Solute carrier transporter disease and developmental and epileptic encephalopathy. | Front Neurol | 2022 | 36419532 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism. | Antioxidants (Basel) | 2022 | 36358574 | PubTator, text mining | PubMed |
| Proteomics unveil a central role for peroxisomes in butyrate assimilation of the heterotrophic Chlorophyte alga Polytomella sp. | Front Microbiol | 2022 | 36353459 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Reversal of mitochondrial malate dehydrogenase 2 enables anaplerosis via redox rescue in respiration-deficient cells. | Mol Cell | 2022 | 36327975 | PubTator, text mining | PubMed |
| Mitochondrial signal transduction. | Cell Metab | 2022 | 36323233 | PubTator, text mining | PubMed |
| Hereditary spastic paraplegia SPG13 mutation increases structural stability and ATPase activity of human mitochondrial chaperonin. | Sci Rep | 2022 | 36316435 | PubTator, text mining | PubMed |
| Transcriptome analysis of Harumi tangor fruits: Insights into interstock-mediated fruit quality. | Front Plant Sci | 2022 | 36311145 | PubTator, text mining | PubMed |
| The α-Ketoglutarate Dehydrogenase Complex as a Hub of Plasticity in Neurodegeneration and Regeneration. | Int J Mol Sci | 2022 | 36293260 | PubTator, text mining | PubMed |
| Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy. | Cancers (Basel) | 2022 | 36291904 | PubTator, text mining | PubMed |
| Inhibition of Malate Dehydrogenase-2 Protects Renal Tubular Epithelial Cells from Anoxia-Reoxygenation-Induced Death or Senescence. | Biomolecules | 2022 | 36291624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4191/papers?page=22